Loading…

Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment

The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The re...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gerontology (Kirkwood) 1987-05, Vol.42 (3), p.265-270
Main Authors: Roghmann, K J, Tabloski, P A, Bentley, D W, Schiffman, G
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c351t-7c04d6749532cc08cf595f0816e2fbaaabdf1096f26ea8653237f034bb4cc7753
cites
container_end_page 270
container_issue 3
container_start_page 265
container_title Journal of gerontology (Kirkwood)
container_volume 42
creator Roghmann, K J
Tabloski, P A
Bentley, D W
Schiffman, G
description The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The results showed differences in antibody levels by sex of the individual (p less than .01 pre and p = .04 at 1 month post), with women having lower antibody levels than men. Women responded better to vaccination than men (p = .05), but they also lost their acquired antibodies faster (p less than .01). No age effect and no effect of level of functioning were observed within this group of elderly individuals. Participants who died had high initial levels and responded well. Major differences between the six types were noticed. Type 6A exhibited the described pattern most clearly, whereas Type 3 often behaved in an opposite pattern from the other five types. We conclude that sex differences persist even among elderly adults, that high levels of antibodies are not necessarily an indicator of good health, and that much unexplained variation between antibody types exist.
doi_str_mv 10.1093/geronj/42.3.265
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77487270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14667702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-7c04d6749532cc08cf595f0816e2fbaaabdf1096f26ea8653237f034bb4cc7753</originalsourceid><addsrcrecordid>eNqF0TFrHDEQBWBhYpyzk9pVQBBI5b2TNFppL50xcWIwuElqodWOzB670kZahfjfR-aOFGlSTTHfPBgeIdecbTnbw-4ZUwyHnRRb2ArVnpGNAOANgIA3ZMOYEA2XQrwllzkfGONCMXVBLqDVvFN8Q9zDPJeANGFeYshIo6c4DZimF2qHMq2ZrpEuAcscXXSu5M_0l02jXccYaF_RM97QjL9vqA0D9SW4142d6DgvdkwzhvUdOfd2yvj-NK_Ij_sv3---NY9PXx_ubh8bBy1fG-2YHJSW-xaEc6xzvt23nnVcofC9tbYffP1ZeaHQdqoq0J6B7HvpnNYtXJFPx9wlxZ8F82rmMTucJhswlmy0lp0Wmv0XcqmU1kxU-PEfeIgl1e-qAca5AMn3Ve2OyqWYc0JvljTONr0YzsxrS-bYkpHCgKkt1YsPp9zSzzj89ada4A88wo7I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1301123419</pqid></control><display><type>article</type><title>Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment</title><source>Oxford University Press Archive</source><creator>Roghmann, K J ; Tabloski, P A ; Bentley, D W ; Schiffman, G</creator><creatorcontrib>Roghmann, K J ; Tabloski, P A ; Bentley, D W ; Schiffman, G</creatorcontrib><description>The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The results showed differences in antibody levels by sex of the individual (p less than .01 pre and p = .04 at 1 month post), with women having lower antibody levels than men. Women responded better to vaccination than men (p = .05), but they also lost their acquired antibodies faster (p less than .01). No age effect and no effect of level of functioning were observed within this group of elderly individuals. Participants who died had high initial levels and responded well. Major differences between the six types were noticed. Type 6A exhibited the described pattern most clearly, whereas Type 3 often behaved in an opposite pattern from the other five types. We conclude that sex differences persist even among elderly adults, that high levels of antibodies are not necessarily an indicator of good health, and that much unexplained variation between antibody types exist.</description><identifier>ISSN: 0022-1422</identifier><identifier>EISSN: 2331-3323</identifier><identifier>DOI: 10.1093/geronj/42.3.265</identifier><identifier>PMID: 3571861</identifier><language>eng</language><publisher>United States: Gerontological Society</publisher><subject>Aged ; Aged, 80 and over ; Antibodies, Bacterial - analysis ; Bacterial Vaccines - immunology ; Female ; Health Services for the Aged ; Humans ; Male ; Pneumococcal Infections - prevention &amp; control ; Prospective Studies ; Sex Factors ; Streptococcus pneumoniae ; Streptococcus pneumoniae - immunology</subject><ispartof>Journal of gerontology (Kirkwood), 1987-05, Vol.42 (3), p.265-270</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-7c04d6749532cc08cf595f0816e2fbaaabdf1096f26ea8653237f034bb4cc7753</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3571861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roghmann, K J</creatorcontrib><creatorcontrib>Tabloski, P A</creatorcontrib><creatorcontrib>Bentley, D W</creatorcontrib><creatorcontrib>Schiffman, G</creatorcontrib><title>Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment</title><title>Journal of gerontology (Kirkwood)</title><addtitle>J Gerontol</addtitle><description>The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The results showed differences in antibody levels by sex of the individual (p less than .01 pre and p = .04 at 1 month post), with women having lower antibody levels than men. Women responded better to vaccination than men (p = .05), but they also lost their acquired antibodies faster (p less than .01). No age effect and no effect of level of functioning were observed within this group of elderly individuals. Participants who died had high initial levels and responded well. Major differences between the six types were noticed. Type 6A exhibited the described pattern most clearly, whereas Type 3 often behaved in an opposite pattern from the other five types. We conclude that sex differences persist even among elderly adults, that high levels of antibodies are not necessarily an indicator of good health, and that much unexplained variation between antibody types exist.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Bacterial - analysis</subject><subject>Bacterial Vaccines - immunology</subject><subject>Female</subject><subject>Health Services for the Aged</subject><subject>Humans</subject><subject>Male</subject><subject>Pneumococcal Infections - prevention &amp; control</subject><subject>Prospective Studies</subject><subject>Sex Factors</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - immunology</subject><issn>0022-1422</issn><issn>2331-3323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNqF0TFrHDEQBWBhYpyzk9pVQBBI5b2TNFppL50xcWIwuElqodWOzB670kZahfjfR-aOFGlSTTHfPBgeIdecbTnbw-4ZUwyHnRRb2ArVnpGNAOANgIA3ZMOYEA2XQrwllzkfGONCMXVBLqDVvFN8Q9zDPJeANGFeYshIo6c4DZimF2qHMq2ZrpEuAcscXXSu5M_0l02jXccYaF_RM97QjL9vqA0D9SW4142d6DgvdkwzhvUdOfd2yvj-NK_Ij_sv3---NY9PXx_ubh8bBy1fG-2YHJSW-xaEc6xzvt23nnVcofC9tbYffP1ZeaHQdqoq0J6B7HvpnNYtXJFPx9wlxZ8F82rmMTucJhswlmy0lp0Wmv0XcqmU1kxU-PEfeIgl1e-qAca5AMn3Ve2OyqWYc0JvljTONr0YzsxrS-bYkpHCgKkt1YsPp9zSzzj89ada4A88wo7I</recordid><startdate>19870501</startdate><enddate>19870501</enddate><creator>Roghmann, K J</creator><creator>Tabloski, P A</creator><creator>Bentley, D W</creator><creator>Schiffman, G</creator><general>Gerontological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOIBA</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19870501</creationdate><title>Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment</title><author>Roghmann, K J ; Tabloski, P A ; Bentley, D W ; Schiffman, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-7c04d6749532cc08cf595f0816e2fbaaabdf1096f26ea8653237f034bb4cc7753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Bacterial - analysis</topic><topic>Bacterial Vaccines - immunology</topic><topic>Female</topic><topic>Health Services for the Aged</topic><topic>Humans</topic><topic>Male</topic><topic>Pneumococcal Infections - prevention &amp; control</topic><topic>Prospective Studies</topic><topic>Sex Factors</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - immunology</topic><toplevel>online_resources</toplevel><creatorcontrib>Roghmann, K J</creatorcontrib><creatorcontrib>Tabloski, P A</creatorcontrib><creatorcontrib>Bentley, D W</creatorcontrib><creatorcontrib>Schiffman, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 29</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gerontology (Kirkwood)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roghmann, K J</au><au>Tabloski, P A</au><au>Bentley, D W</au><au>Schiffman, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment</atitle><jtitle>Journal of gerontology (Kirkwood)</jtitle><addtitle>J Gerontol</addtitle><date>1987-05-01</date><risdate>1987</risdate><volume>42</volume><issue>3</issue><spage>265</spage><epage>270</epage><pages>265-270</pages><issn>0022-1422</issn><eissn>2331-3323</eissn><abstract>The immune response of 271 elderly persons to the new 23-valent pneumococcal vaccine was studied prospectively. Sera were obtained prevaccination, at 1 month post- and 12 months postvaccination. They were analyzed by radioimmunoassay for the presence of antibody Types 1, 3, 6A, 7F, 8, and 9N. The results showed differences in antibody levels by sex of the individual (p less than .01 pre and p = .04 at 1 month post), with women having lower antibody levels than men. Women responded better to vaccination than men (p = .05), but they also lost their acquired antibodies faster (p less than .01). No age effect and no effect of level of functioning were observed within this group of elderly individuals. Participants who died had high initial levels and responded well. Major differences between the six types were noticed. Type 6A exhibited the described pattern most clearly, whereas Type 3 often behaved in an opposite pattern from the other five types. We conclude that sex differences persist even among elderly adults, that high levels of antibodies are not necessarily an indicator of good health, and that much unexplained variation between antibody types exist.</abstract><cop>United States</cop><pub>Gerontological Society</pub><pmid>3571861</pmid><doi>10.1093/geronj/42.3.265</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1422
ispartof Journal of gerontology (Kirkwood), 1987-05, Vol.42 (3), p.265-270
issn 0022-1422
2331-3323
language eng
recordid cdi_proquest_miscellaneous_77487270
source Oxford University Press Archive
subjects Aged
Aged, 80 and over
Antibodies, Bacterial - analysis
Bacterial Vaccines - immunology
Female
Health Services for the Aged
Humans
Male
Pneumococcal Infections - prevention & control
Prospective Studies
Sex Factors
Streptococcus pneumoniae
Streptococcus pneumoniae - immunology
title Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A54%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20response%20of%20elderly%20adults%20to%20pneumococcus:%20variation%20by%20age,%20sex,%20and%20functional%20impairment&rft.jtitle=Journal%20of%20gerontology%20(Kirkwood)&rft.au=Roghmann,%20K%20J&rft.date=1987-05-01&rft.volume=42&rft.issue=3&rft.spage=265&rft.epage=270&rft.pages=265-270&rft.issn=0022-1422&rft.eissn=2331-3323&rft_id=info:doi/10.1093/geronj/42.3.265&rft_dat=%3Cproquest_cross%3E14667702%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c351t-7c04d6749532cc08cf595f0816e2fbaaabdf1096f26ea8653237f034bb4cc7753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1301123419&rft_id=info:pmid/3571861&rfr_iscdi=true